US2003206881A1PendingUtilityA1

Phospholipidic composition as well as the use thereof

Priority: May 31, 2001Filed: May 31, 2001Published: Nov 6, 2003
Est. expiryMay 31, 2021(expired)· nominal 20-yr term from priority
A23J 7/00
27
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A phospholipidic composition with an L-α-glycerophosphatidyl-choline concentration of at least 10% by weight is described, where said composition is granular also contains, in addition to L-α-glycerophosphatidylcholine, at least one granulation aid selected from the group consisting of a monophosphate, diphosphate or triphosphate of an alkali metal or an alkaline earth metal or a mixture thereof.

Claims

exact text as granted — not AI-modified
1 . A phospholipidic composition with a concentration of L-α-glycerophosphatidylcholine of at least 10% by weight, characterized in that the composition consists of granules and, in addition to containing L-α-glycerophosphatidylcholine, the composition also contains at least one granulation aid selected from the group consisting of a monophosphate, diphosphate or triphosphate of an alkali metal or an alkaline earth metal or a mixture thereof  
     
     
         2 . The phospholipidic composition according to  claim 1 , characterized in that the composition contains the granulation aid in a concentration between 2-% by weight and 50% by weight.  
     
     
         3 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition contains the granulation aid in a concentration between 10% by weight and 30% by weight.  
     
     
         4 . The phospholipidic composition according to one of the preceding claims, characterized in that the granules have a particle size between 0.063 mm and 5 mm.  
     
     
         5 . The phospholipidic composition according to one of the preceding claims, characterized in that cellulose and/or silicon dioxide is also present in the composition.  
     
     
         6 . The phospholipidic composition according to  claim 5 , characterized in that the cellulose concentration in the composition is between 0.5% by weight and 30 by weight.  
     
     
         7 . The phospholipidic composition according to  claim 6 , characterized in that the cellulose concentration in the composition is between 5% by weight and 20% by weight.  
     
     
         8 . The phospholipidic composition according to one of claims  5  till  7 , characterized in that the cellulose has an average particle size between 60 μm and 150 μm, preferably between 90 μm and 120 μm.  
     
     
         9 . The phospholipidic composition according to one of claims  5  till  8 , characterized in that the silicon dioxide concentration in the composition varies between 0.5% by weight and 3% by weight, preferably between 1% by weight and 2% by weight.  
     
     
         10 . The phospholipidic composition according to one of claims  5  till 9, characterized in that the silicon dioxide has a particle size between 5 nm and 25 nm, preferably between 10 nm and 20 nm.  
     
     
         11 . The phospholipidic composition according to one of claims  5  till  10 , characterized in that the silicon dioxide has a surface area between 100 m 2 /g and 300 m 2 /g, preferably between 150 m 2 /g and 250 m 2 /g.  
     
     
         12 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition contains at least one calcium salt of phosphoric acid as a granulation aid.  
     
     
         13 . The phospholipidic composition according to  claim 12 , characterized in that the calcium salt of phosphoric acid is tricalcium phosphate.  
     
     
         14 . The phospholipidic composition according to one of the preceding claims, characterized in that the tricalcium phosphate contains less than 10% by weight monocalcium phosphate and/or less than 10% by weight dicalcium phosphate, each based on the total amount of said tricalcium phosphate.  
     
     
         15 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition is free of usual binders.  
     
     
         16 . The phospholipidic composition according to one of the preceding claims, characterized in that the concentration of L-α-glycerophosphatidylcholine in the composition is greater than 70% by weight.  
     
     
         17 . The phospholipidic composition according to  claim 16 , characterized in that the concentration of L-α-glycerophosphatidylcholine in the composition is between 80% by weight and 95% by weight.  
     
     
         18 . The phospholipidic composition according to one of claims  1  till  16 , characterized in that the composition contains 
 10 to 80% by weight L-α-glycerophosphatidylcholine  
 0 to 40% by weight cellulose  
 0.5 to 50% by weight calcium monophosphate, calcium diphosphate and/or calcium triphosphate, and  
 0.5 to 3% by weight silicon dioxide.  
 
     
     
         19 . The phospholipidic composition according to  claim 18 , characterized in that the composition contains 
 40 to 70% by weight L-α-glycerophosphatidylcholine    10 to 30% by weight cellulose    10 to 30% by weight calcium monophosphate, calcium disphosphate and/or calcium triphosphate, and    1.5 to 2.5% by weight silicon dioxide.    
     
     
         20 . The phospholipidic composition according to one of the preceding claims, characterized in that the L-α-glycerophosphatidylcholine is of vegetable origin and is isolated from soybeans in particular.  
     
     
         21 . The use of the phospholipidic composition according to one of claims  1  till  20  in food products, cosmetics or pharmaceutical products.

Join the waitlist — get patent alerts

Track US2003206881A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.